Skip to content

ADJUSTment Disorder in Cancer Patients: Effectiveness and Cost-Utility of Tailored Psychological Treatment

ADJUSTment Disorder in Cancer Patients: Effectiveness and Cost-Utility of Tailored Psychological Treatment - ADJUST-study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55359
Enrollment
206
Registered
2019-04-09
Start date
2019-02-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adjustment disorder Cancer

Interventions

The psychological intervention investigated in this proposed project follows the guideline on diagnosis of adjustment disorders and consists of 3 modules, namely module 1 encompassing a maximum of 4

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * age * 18 years; * diagnosed with cancer (all types and stages, except non-melanoma skin cancer); * patients after the end of primary cancer treatment with curative or palliative intent (all treatment modalities, except for endocrine therapy in breast/prostate cancer), * presence of an adjustment disorder as diagnosed with a diagnostic interview.

Exclusion criteria

Exclusion criteria: Patients who are not able to complete a Dutch questionnaire.

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is psychological distress, as measured using the Hospital Anxiety and Depression Scale.

Secondary

MeasureTime frame
Secondary outcome measures of this study are coping, measured using the Mental Adjustment to Cancer Scale, and quality of life as measured using the EORTC QLQ-C30. In addition, the cost-utility of the psychological intervention will be investigated. Costs will be measured using the medical consumption questionnaire (iMCQ) and productivity cost questionnaire (iPCQ). The EQ-5D-5L will be used to measure quality-adjusted life-years.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)